Skip to content
10-Q

Quarterly Report

GlobeStar Therapeutics Corp

0001161697-24-000420

← back to feed
Filed
Oct 11, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Oct 4, 2024 1.24B sh
Operating Cash Flow Q3 2024 · Jun 30, 2024 −$75.59K
Operating Cash Flow Q3 2024 · Jun 30, 2023 −$133.07K
Cash And Equivalents Q3 2024 · Jun 30, 2024 $41
Stockholders Equity Q3 2024 · Jun 30, 2024 −$1.62M
Stockholders Equity Q3 2024 · Mar 31, 2024 −$1.47M
Stockholders Equity Q3 2024 · Dec 31, 2023 −$1.53M
Stockholders Equity Q3 2024 · Sep 30, 2023 −$1.43M
Stockholders Equity Q3 2024 · Jun 30, 2023 −$1.28M
Stockholders Equity Q3 2024 · Mar 31, 2023 −$1.29M
Stockholders Equity Q3 2024 · Dec 31, 2022 −$1.24M
Stockholders Equity Q3 2024 · Sep 30, 2022 −$1.19M
Current Liabilities Q3 2024 · Jun 30, 2024 $1.71M
Current Liabilities Q3 2024 · Sep 30, 2023 $1.43M
Total Liabilities Q3 2024 · Jun 30, 2024 $1.71M
Total Liabilities Q3 2024 · Sep 30, 2023 $1.43M
Current Assets Q3 2024 · Jun 30, 2024 $83.87K
Total Assets Q3 2024 · Jun 30, 2024 $83.87K
Net Income Q3 2024 · Jun 30, 2024 −$197.66K
Net Income Q3 2024 · Jun 30, 2024 −$536.38K
Net Income Q3 2024 · Mar 31, 2024 −$174.96K
Net Income Q3 2024 · Dec 31, 2023 −$163.76K
Net Income Q3 2024 · Jun 30, 2023 −$1.28M
Net Income Q3 2024 · Jun 30, 2023 −$1.6M
Net Income Q3 2024 · Mar 31, 2023 −$150.24K
Net Income Q3 2024 · Dec 31, 2022 −$165.91K
Operating Income Q3 2024 · Jun 30, 2024 −$193.36K
Operating Income Q3 2024 · Jun 30, 2024 −$516.81K
Operating Income Q3 2024 · Jun 30, 2023 −$1.28M
Operating Income Q3 2024 · Jun 30, 2023 −$1.58M
Stock Issued Q3 2024 · Feb 28, 2022 6M sh